Head/Neck Cancer

Top Story

Immunotherapy provides ‘paradigm shift’ for treatment of head and neck cancer

Immunotherapy provides ‘paradigm shift’ for treatment of head and neck cancer
HemOnc Today, May 25, 2018

Obesity linked to 12 cancer types

May 24, 2018
Overweight and obesity appeared associated with an increased risk for 12 cancer types, according to World Cancer Research Fund’s new report. The report shows…
In the Journals Plus

US cancer deaths continue to decline

May 22, 2018
Cancer deaths continue to decline among men, women and children in the United States, according to the Annual Report to the Nation on the Status of Cancer. Deaths due to…
In the Journals Plus

HPV vaccine follow-through rates decline sharply

May 17, 2018
Follow-through with the HPV vaccine is poor and has become worse over time, according to researchers from the University of North Carolina, Chapel Hill. “Increases…
More Headlines »

Immune Checkpoint Inhibitors for Genitourinary Cancers: Practice Essential for Community Oncologists and Advanced Practice Providers

This activity is supported by an educational grant from Merck & Co., Inc.

For many years, the mainstay of initial treatment for metastatic bladder cancer has been chemotherapy. However…
More »
Meeting News

VIDEO: Role of adjuvant chemotherapy in nasopharynx cancer remains uncertain

June 19, 2017
More »
Resource Centers
Immuno-Oncology Resource Center

Immuno-Oncology Resource Center


Ace the Case: A 35-Year-Old Man Presents to a Dermatologist with a Brown Pigmented Lesion That Has Been Changing over the past 3 Months

There is no commercial support for this activity.

This educational activity will utilize a case study to discuss the diagnosis and management of a 35-year-old man who…
More »